Efficacy and safety of denosumab for the treatment of osteoporosis in patients with renal failure
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 13 Apr 2019 Status changed from active, no longer recruiting to completed.
- 12 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 06 Jul 2017 Status changed from completed to recruiting.